Lyell Immunopharma Statistics

Total Valuation

LYEL has a market cap or net worth of $535.76 million. The enterprise value is $260.42 million.

Market Cap	535.76M
Enterprise Value	260.42M

Important Dates

The last earnings date was Wednesday, November 12, 2025, after market close.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

LYEL has 21.22 million shares outstanding. The number of shares has increased by 21.43% in one year.

Current Share Class	21.22M
Shares Outstanding	21.22M
Shares Change (YoY)	+21.43%
Shares Change (QoQ)	+23.49%
Owned by Insiders (%)	2.37%
Owned by Institutions (%)	33.54%
Float	12.17M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	13,067.32
Forward PS	n/a
PB Ratio	1.48
P/TBV Ratio	1.63
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	6,351.73
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.30, with a Debt / Equity ratio of 0.13.

Current Ratio	10.30
Quick Ratio	10.03
Debt / Equity	0.13
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -75.75% and return on invested capital (ROIC) is -25.78%.

Return on Equity (ROE)	-75.75%
Return on Assets (ROA)	-24.16%
Return on Invested Capital (ROIC)	-25.78%
Return on Capital Employed (ROCE)	-52.79%
Revenue Per Employee	$137
Profits Per Employee	-$1.09M
Employee Count	300
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +35.18% in the last 52 weeks. The beta is -0.11, so LYEL's price volatility has been lower than the market average.

Beta (5Y)	-0.11
52-Week Price Change	+35.18%
50-Day Moving Average	18.20
200-Day Moving Average	12.50
Relative Strength Index (RSI)	68.72
Average Volume (20 Days)	44,382

Short Selling Information

The latest short interest is 163,125, so 0.77% of the outstanding shares have been sold short.

Short Interest	163,125
Short Previous Month	166,193
Short % of Shares Out	0.77%
Short % of Float	1.34%
Short Ratio (days to cover)	6.13

Income Statement

In the last 12 months, LYEL had revenue of $41,000 and -$325.66 million in losses. Loss per share was -$21.06.

Revenue	41,000
Gross Profit	41,000
Operating Income	-198.55M
Pretax Income	-325.66M
Net Income	-325.66M
EBITDA	-184.38M
EBIT	-198.55M
Loss Per Share	-$21.06

Full Income Statement

Balance Sheet

The company has $319.62 million in cash and $44.29 million in debt, giving a net cash position of $275.34 million or $12.98 per share.

Cash & Cash Equivalents	319.62M
Total Debt	44.29M
Net Cash	275.34M
Net Cash Per Share	$12.98
Equity (Book Value)	329.12M
Book Value Per Share	17.06
Working Capital	296.32M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$165.02 million and capital expenditures -$520,000, giving a free cash flow of -$165.54 million.

Operating Cash Flow	-165.02M
Capital Expenditures	-520,000
Free Cash Flow	-165.54M
FCF Per Share	-$7.80

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-484,265.85%
Pretax Margin	-794,292.68%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LYEL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-21.43%
Shareholder Yield	-21.43%
Earnings Yield	-60.78%
FCF Yield	-30.90%

Analyst Forecast

The average price target for LYEL is $16.67, which is -34.55% lower than the current price. The consensus rating is "Buy".

Price Target	$16.67
Price Target Difference	-34.55%
Analyst Consensus	Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	342.10%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 2, 2025. It was a reverse split with a ratio of 1:20.

Last Split Date	Jun 2, 2025
Split Type	Reverse
Split Ratio	1:20

Scores

LYEL has an Altman Z-Score of -4.32 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.32
Piotroski F-Score	1